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Abstract Lymphedema is a ubiquitous chronic disease
with various suggested treatment options, but no definite
treatment. Using (Sequential) Intermittent Pneumatic Com-
pression (SIPC) is one of the most appropriate non-surgical
treatments without any noticeable complications. In this
study, we evaluated the serum lipids changes following
SIPC. Participants included 40 lower limb lymphedema
patients who underwent High Pressure SIPC for a period of
48 hrs. Pre and Post SIPC serum lipids changes were
evaluated. Though, there was some increase in the serum
level of cholesterol and triglyceride, none of the patients
had the values above the normal range. We concluded that,
the fluid entering the serum during SIPC, contain large
molecules such as lipids, which increases serum lipid
levels. However this phenomenon does not have any
significant complication for the patients.
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Introduction
Lymphedema is regarded as chronic accumulation of lymph
in the soft tissues.
Over 19 million people are involved with the ubiquitous
disease [1]. Among secondary subtype which is more
common than the primary ones, surgical lymph node
dissection in industrial countries and post infectious
lymphedema in developing countries are the most common
causes [2]. Various complications such as skin dryness and
thinning, abnormal and deep folds of the skin, soft tissue
recurrent infections and malignancies were identified for
the patients, especially in prolonged disease.
Despite various suggested treatment options, there is no
definite medical or surgical treatment for the disease.
The Sequential Intermittent Pneumatic Compression
(SIPC) is one of the most common and safest modality of
medical treatment for driving out lymph from the extremity.
Although, no significant complications have yet been
identified for this method [1, 3–5] ,t h e r ei ss o m ec o n c e r n
about the hemodynamic and biochemical changes, as well as
soft tissue damage after SIPC usage. Previous studies on
hemodynamic changes indicated that in patients with conges-
tive heart failure or renal problems, there is the possibility of
pulmonary edema following SIPC therapy due to resulting
volume over load. Therefore, in these patients it is necessary
to use lower pressures for a short period of time [1]. Also,
study of the modality on muscle tissue damage did not show
any significant increase in muscle enzyme levels [3].
Since lymph fluid contains high concentration of lipids,
entrance of high quantity of lymph to the serum during SIPC
therapy can be theoretically considered as a complication of the
modality. However, as far as we know, no particular study has
yet been performed on the matter. In this study we evaluated
serum lipid changes following SIPC in lymphedema patients.
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sequentially selected lymphedema patients with the age
range of 17 to 71 years (mean: 31). 24 patients had primary
involvement and the other remaining 16 suffered from
secondary lymphedema.
8 male (6 patients with primary involvement: 25%) and
32 females (18 cases with primary involvement: 75%) were
evaluated in this study. Surgery (37.5%) and trauma (31%)
were the commonest causes of the secondary lymphedema.
Four patients with a less than one year history of
lymphedema, 18 patients suffered from the disease for 1
to 4 years, 3 patients for 4 to10 years and the remainder 11
for more than 10 years (there was no reliable information
for the remaining 4). Thirty patients (75%) have got
unilateral involvement (16 cases with primary involvement:
66%) while, bilateral involvement was seen in 10 (25%)
patients (8 cases with primary involvement: 34%). All of
the patients had lower extremity involvement.
Patients with congestive heart failure, as well as patients
known to suffer from renal dysfunction, hepatic failure and
lower limbs venous or arterial insufficiency were excluded
from the study.
None of them had an experience of using the SIPC
devices formerly.
Patients were hospitalized for 48 hrs. Before beginning
the therapy, a baseline fasting serum lipid levels were
evaluated as a basic criterion in all patients.
During hospital stay, using the Pneumolymph®
1 device
the involved limb was subjected to a standard pressure for 2
consecutive days (included 8 hours daily). The patients
used regular diet during the hospitalization and post
treatment sampling time for evaluation of serum lipid level
[1] A SIPC device manufactured in Iran was arranged so as
to be at least 8 hours after the meal [6]. For this purpose
during SIPC using, the patients didn’t have anything.
Finally, pre and post treatment serum lipid levels were
compared and analyzed.
Among the studied patients, at initial evaluation 8 cases
suffered from hypertriglyceridemia and 4 cases from
hypercholesterolemia. Since pre and post SIPC levels of
serum lipid changes (not its absolute amount) was to be
evaluated, above patients were not excluded from the study.
After data collection, statistically analysis was performed
using SPSS (version 16), by means of pare t-test ±2SE for
determination of confidence interval of 95%.
Results
The pre SIPC mean serum triglyceride levels was 119.3 mg/
dl (SD: 95.3), and the mean of serum cholesterol levels was
176.25 mg/dl (SD: 59), whereas post SIPC mean of serum
triglyceride levels was 121.3 mg/dl (SD: 64.85) and mean
of serum cholesterol levels was 189.75 mg/dl (SD: 56.11).
In 87.5% of individuals, post SIPC triglyceride levels
showed an increase (p=0.031). Also, for 85% of patients,
there was an increase of cholesterol levels (p=0.000).
In all of the patients with normal serum triglyceride and
cholesterol levels, the rising did not exceed the upper limit
of the normal range.
During the treatment session, no complications attributed
to the use of SIPC were observed.
There is no relation between post SIPC increase of
serum lipid levels and the number of involved limb as well
as the etiology of the disease.
Discussion
As previously mentioned, although absolute count of
triglyceride and cholesterol were increased 2 and 13.5 mg/
dl after intervention, there is a statistically significant
difference between pre and post SIPC serum levels. Also
all parameters that could change the lipid levels (such as
diet) were fixed in our study, so the cause of these changes
only can be due to the intervention. Specially these changes
were seen in many of patients (85–87.5%) not in some of
them. It suggests that large molecules such as lipoproteins
can pass into the circulatory system during SIPC usage
which contradicts some researchers’ belief indicating that it
is only water molecules that enter into the circulatory
system which makes transient and unreliable decrease in
limb size during SIPC therapy [7]. In fact, increase of
serum lipids levels shows that proper use of SIPC in early
stages of the disease could prevent chronic accumulation of
the lymph, and its subsequent complications, especially
fibrosis formation. The question that is raised, is whether
lymph entrance as a lipid rich fluid into the serum
following SIPC therapy, may have complications of
transient hyperlipidemia? Since lymphedema patients
should be frequently undergone the treatment, so the
subsequent hyperlipidemia shows a similar pattern to that
of postprandial hyperlipidemia. In the postprandial hyper-
lipidemia phenomenon, following a high fat meal, lip-
oproteins which contain high quantity of triglycerides enter
into the serum. Many studies indicate the role of the
postprandial hyperlipidemia in accelerating atherosclerosis
and its relation with the cardiovascular events [6, 8–12],
but this is due to increasing the lipids level above the
normal range.
Our study suggested increased serum lipid levels
following SIPC therapy, but the values were not out of
normal ranges. It means that in spite of the increase
observed in postprandial hyperlipidemia, the episodic
1 A SIPC device manufactured in Iran
306 Indian J Surg (July–August 2010) 72(4):305–307increase of the serum lipids following SIPC therapy is
not clinically significant and the subsequent risks do not
matter. So, the therapy is safe in the management of
lymphedema.
We concluded that, despite the increase of lipid levels in
serum following SIPC therapy which proves entrance of large
molecules from interstitium to the blood vessels, the levels
remain in normal range, which indicates safety of the this
treatment with no worry about the episodic hyperlipidemia.
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